A promising drug shows results in reducing the effects of Alzheimer’s disease
Alzheimer’s disease is currently the largest unmet medical need in neurology. More than 44 million people live with dementia worldwide, with Alzheimer’s being the most common form. As aging populations expand, it is critical that better treatments become available. George Clinical is currently managing a clinical trial in Australia of a new drug whose preliminary […]
Read More
